# Pharmaceutical R&D

Monetizing the Pulse: China’s Hospital Data Gold Rush and the Erosion of Patient Privacy

China's public hospitals are increasingly selling patient datasets to pharmaceutical and AI companies under a state-led mandate to monetize 'data elements.' While this fuels medical innovation, it raises significant legal and ethical questions regarding patient privacy and the lack of specific informed consent for commercial data use.